Credit: Network Middle East Abundance 360 (A360) Summit explores advances in exponential technology Ever heard of exponential technology? You might soon as the ‘Davos for Exponential Tech’ makes its Middle East debut this year in Dubai. The Abundance 360 (A360) Summit…
Author: Alisha Moopen, Executive Director and CEO – Aster DM Healthcare In today’s world, where we are constantly challenged by issues like growing inequality, poverty, evolving health and environmental risks; we as business leaders are always faced with hard questions…
Chinese Capital Controls? The year 2017 saw Beijing simultaneously tightening and ‘relaxing’ its outbound foreign direct investment (OFDI) protocols. In a somewhat confusing move, following a strew of disastrous Chinese investment decisions, and set against a background of politicking among…
While the world debates the virtues of private vs public healthcare, the GCC is busy pioneering medtech advances that transform lives. The healthcare industry in the GCC can be difficult to understand. On the one hand, the GCC is a…
A high-level delegation from business facilitation company Naseba invited for the Annual Investor Meeting of E-fung Capital, supporting deals in pharmaceuticals and portfolio companies DUBAI – With ambitions to boost private equity and venture capital investment in China, a high-level…
As connectivity continues to enable and improve people’s lives around the world, we are seeing some incredibly transformative impacts across all aspects of human life. Just take a minute to think about the way you currently communicate, access information, consume…
This year, the World Economic Forum was dominated with talk of healthcare’s high-tech revolution, from lab bench to bedside… and not a “robot” in sight. The digital revolution is commonly associated with communications and information, characterised by the internet, digital…
Rising incomes and a growing middle class in China is boosting investment into healthcare, pharmacy and self-care. This was recently highlighted by the announcement that a Chinese investor group will be acquiring the condom division of Ansell Ltd, the world’s…
The healthcare system in GCC territories has become a growing concern in recent years. Beyond problems such as a growing population and a higher average lifespan, countries’ such as Saudi Arabia and Qatar have become host to some of the…
UAE’s Mubadala Development Co have announced an investment coalition with the Chinese conglomerate HNA Group, revealing very few details about specific future investments, and leaving much excitement to the imagination. Between the two investor groups, new projects could have access…
The transformation of GCC economies, attempting to break from the traditional oil based capital, has been underway for some time. Looking towards a knowledge and technology based portfolio has proven fruitful for a number of countries, particularly within the healthcare…
China based conglomerate AUX Group has announced plans to seek health services investments in the US and Britain, according to recent reports. The company has 8.2 billion USD in total assets and was named among China’s top 500 enterprises. The…
Investors based in the Middle East and regional healthcare companies having been actively seeking acquisitions and investment opportunities in the US. Overseas investments provide Middle Eastern individuals and institutions with a way to diversify their portfolios, rather than overexposing their…
The Middle East is experiencing rising demand for high quality, innovative healthcare solutions. This is particularly true for the region’s largest healthcare market – Saudi Arabia. Saudi entities are increasingly willing to invest in healthcare companies overseas in order to…
In May 2016, Chinese investment group Creat Group agreed to acquire UK-based Bio Products Laboratory for 820 million GBP (1.1 billion USD). Headquartered in Hertfordshire, Bio Products Laboratory is a plasma biotherapeutics company that provides therapeutics for conditions related to…